22 New Dispensary Licenses, Federal Rescheduling, and the Strains Dominating Florida This Spring

Florida's medical cannabis market is in the middle of its most transformative year since Amendment 2 passed in 2016. Between new dispensary licenses, federal rescheduling, industry acquisitions, and an absolute fire lineup of new strains hitting shelves, there's a lot for patients to be excited about this spring.

Let's break down what's happening and what it means for your wallet, your medicine, and your options.

22 New MMTC Licenses Are Coming This Summer

This is the big one. Florida is expected to issue 22 new Medical Marijuana Treatment Center (MMTC) licenses by summer 2026, and the impact on patients could be massive.

Right now, Florida's roughly 800,000 medical marijuana patients are served by a relatively small number of vertically integrated license holders. More licenses mean more competition, and competition in a regulated market almost always leads to three things patients love: lower prices, more locations, and better product selection.

The new licensees will be required to grow, process, and dispense their own products — the same vertical integration model existing MMTCs follow. But fresh operators mean fresh genetics, new brands, and potentially aggressive pricing as newcomers fight for market share.

What this means for you: If you've been loyal to one dispensary out of convenience, this summer is the time to shop around. New players will be hungry for patients, and that usually translates to opening-day deals, loyalty programs, and competitive pricing.

Federal Rescheduling: What Actually Changed in April

In April 2026, the federal government reclassified certain FDA-approved and state-issued medical cannabis products into Schedule III. This is not full legalization — recreational cannabis remains federally illegal — but it's a meaningful shift.

Here's what Schedule III means in practice:

• Federal recognition of state-licensed medical cannabis systems like Florida's
• More research opportunities as institutional barriers to cannabis studies ease
• Potential tax relief for cannabis businesses, which could eventually lower consumer prices
• Greater acceptance in healthcare, making it easier for doctors to discuss medical cannabis openly

A federal court hearing on whether to move all marijuana from Schedule I to Schedule III is scheduled for June 29, 2026. If that broader rescheduling goes through, it could reshape the entire industry.

What this means for you: Day-to-day, not much changes yet. But the trend line is clear — medical cannabis is being treated more like legitimate medicine at the federal level, and that's a win for every patient in Florida.

Industry Shakeups: Vireo Acquires FLUENT, Trulieve Goes Domestic

The corporate side of Florida cannabis is moving fast too.

Vireo Growth acquired FLUENT in an all-stock deal, substantially expanding their Florida footprint. If you're a FLUENT patient, expect potential rebranding, menu changes, and possibly new product lines as Vireo integrates the operation. Keep an eye on your loyalty points and any transition communications.

Meanwhile, Trulieve announced on May 13 that it's seeking shareholder approval to move its corporate domicile from British Columbia, Canada, to Delaware. Trulieve already operates more Florida dispensaries than anyone else, and this move aligns its corporate structure with its actual U.S. operations. For patients, it's a structural change that signals long-term commitment to the Florida market.

Spring 2026 Strains You Need to Try

Enough policy talk — let's get to the good stuff. Florida dispensaries are absolutely loaded with heat right now. Here are the strains patients and budtenders can't stop talking about:

Toad Venom (Sativa-Dominant)

THC: 28-33% | Top Terpenes: Limonene, Caryophyllene

The breakout strain of 2026. Toad Venom delivers an uplifting cerebral buzz with just enough physical relaxation to keep you grounded. Patients report it's excellent for daytime fatigue, mood enhancement, and stress relief without the couch-lock. Find it at The Flowery and Jungle Boys.

Purple Apricot (Indica-Dominant)

THC: 25-29% | Top Terpenes: Linalool

Deep physical relaxation without the heavy sedation that kills your evening. Purple Apricot's linalool-forward profile makes it ideal for insomnia, muscle spasms, and chronic pain. Available at Sunburn and Curaleaf.

Tropicana Cherry (Balanced Hybrid)

THC: 24-28% | Top Terpenes: Myrcene, Limonene

Sweet citrus-cherry flavor with functional euphoria. This one lets you stay productive while thoroughly enjoying yourself. Widely available at MUV, RISE, and Trulieve.

Apples & Bananas (Balanced Hybrid)

THC: 25-30% | Top Terpenes: Varies by phenotype

A complex genetic cross that delivers both mental stimulation and physical comfort. Consistently one of the top-selling hybrids in Florida and widely stocked at MUV, Trulieve, and The Flowery.

Georgia Pie (Hybrid)

THC: 26-30% | Top Terpenes: Caryophyllene, Limonene

A cross of Gelatti and Larry Bird with an unmistakable peach-cobbler aroma. Potent, uplifting, and perfect for patients who want strong effects without being glued to the couch.

New Products Worth Watching

Beyond flower, dispensaries are dropping fresh products worth exploring:

• Select Briq 2 by Curaleaf — Enhanced flavor with real-time dose visibility on the device. If you've been frustrated by vape carts that feel inconsistent, this is worth a try.
• Float 2g Vape Lineup by Surterra — Bigger capacity, bigger flavor, longer sessions. Surterra's new vape line is designed for patients who want more from each cartridge.
• Anthem Pre-Rolls by Curaleaf — Convenient, consistent, and priced right for patients who prefer not to grind and roll.

Legislation Watch: What Didn't Happen (And Why It Matters)

The 2026 Florida legislative session ended March 13 with zero cannabis policy reforms enacted. Two notable bills died:

• SB 776 would have allowed patients to grow up to six flowering plants at home. It died in committee.
• SB 1032 would have increased supply limits and slashed veteran MMJ card fees from $75 to $15. It passed the Senate Health Policy Committee but didn't make it to a floor vote.

The recreational legalization ballot initiative also failed to gather enough signatures for the 2026 ballot, meaning the earliest voters could see it again is 2028.

What this means for you: Florida's medical cannabis program stays as-is for now. No home grow, no expanded supply limits, and recreational cannabis remains illegal. The program works — it's just not getting better through legislation this year.

Hemp Products: A Looming Deadline

One more thing to watch: a federal spending bill passed in late 2025 could reclassify most consumable hemp products as marijuana by November 2026. This would effectively end direct-to-consumer shipping of intoxicating hemp products like delta-8 THC gummies and THCA flower.

The Florida legislature had a chance to create state-level exemptions during the 2026 session but didn't act. If you use hemp-derived products, stock up before fall and stay tuned — this space is changing fast.

The Bottom Line

Spring 2026 is a moment of expansion and transition for Florida cannabis. New dispensaries are coming. Federal recognition is growing. The strain menu has never been better. And while the legislature didn't give patients any wins this session, the market itself is delivering through competition and innovation.

Stay smart. Shop deals. Try something new.

---

Looking for the best prices on these strains and more? Browse live deals from Florida's top dispensaries at CannaDeals FL.